Cancer Genetics Inc (CGIX) Stock Price & Overview
NASDAQ:CGIX
Current stock price
The current stock price of CGIX is 4.61 null. Today CGIX is down by -2.33%. In the past month the price decreased by -21.73%. In the past year, price increased by 45.89%.
CGIX Key Statistics
- Market Cap
- 18.832M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.25
- Dividend Yield
- N/A
CGIX Stock Performance
CGIX Stock Chart
CGIX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CGIX. When comparing the yearly performance of all stocks, CGIX is one of the better performing stocks in the market, outperforming 76.32% of all stocks.
CGIX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CGIX. Both the profitability and financial health of CGIX have multiple concerns.
CGIX Earnings
CGIX Forecast & Estimates
CGIX Financial Highlights
Over the last trailing twelve months CGIX reported a non-GAAP Earnings per Share(EPS) of -1.25. The EPS increased by 60.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -71.5% | ||
| ROA | -46.7% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CGIX Ownership
About CGIX
Company Profile
Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey.
Company Info
Cancer Genetics Inc
201 ROUTE 17 NORTH 2ND FLOOR
RUTHERFORD NJ 07070
CEO: John A. Roberts
Phone: 201-528-9200
Cancer Genetics Inc / CGIX FAQ
Can you describe the business of Cancer Genetics Inc?
Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey.
What is the current price of CGIX stock?
The current stock price of CGIX is 4.61 null. The price decreased by -2.33% in the last trading session.
Does Cancer Genetics Inc pay dividends?
CGIX does not pay a dividend.
How is the ChartMill rating for Cancer Genetics Inc?
CGIX has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of Cancer Genetics Inc (CGIX) based on its PE ratio?
Cancer Genetics Inc (CGIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.25).
Can you provide the market cap for Cancer Genetics Inc?
Cancer Genetics Inc (CGIX) has a market capitalization of 18.83M null. This makes CGIX a Nano Cap stock.